Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects
- 22 May 2024
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 199, 104390
Abstract
No abstract availableKeywords
Funding Information
- Soochow University
This publication has 59 references indexed in Scilit:
- Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cellsAmerican Journal of Hematology, 2022
- Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphomaCancer Medicine, 2021
- Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Induction Radiation Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Non-Hodgkin LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapyAmerican Journal of Hematology, 2019
- Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Rates and Durability of Response to Salvage Radiation Therapy Among Patients With Refractory or Relapsed Aggressive Non-Hodgkin LymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab EraInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin’s lymphomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006